CAGR

Pluri's subsidiary Cellav just won UK approval for its aesthetic product. But the real story is the science and a market potentially 4x larger than stated.

As global temperatures rise, international buyers are rewriting the rules of trade. The Canton Fair reveals a new mandate: innovation for a warmer world.

Once a trade-only bazaar, the NAMM Show has transformed into a global digital marketplace fueled by creators. Joyce Watson unpacks the business implications.

Monika Alcobev’s partnership with Angostura isn't just a brand launch; it’s a bet on India's maturing market and a new playbook for building resilient global brands.

Leveraging its global dominance in human medicine, Jiangxi Bio is entering the booming veterinary market with a new production line, a key move in its growth strategy.

As InCred Asset Management crosses a key milestone, we decode the strategy and the powerful structural trends fueling India's next big investment boom.

With its second global plant in Thailand, NatureWorks doubles down on Asia, challenging the plastics industry and testing the limits of a green economy.

Aukera's Chennai debut isn't just a new store; it's a calculated move in the lab-grown diamond revolution, reshaping India's luxury market from the ground up.

IKO Commercial is betting on hyper-local expertise, appointing three sales agencies to deepen its U.S. footprint. Is this the key to unlocking growth?

A series of decisive legal victories in the U.S. and Europe has given food giant Danone a powerful grip on the future of a key gut health microbe.

As artificial intelligence pushes server racks to furnace-like temperatures, a quiet industrial revolution is underway. The market for liquid cooling is exploding.

Following its acquisition by Kirin, Blackmores is launching a new brain supplement. This move tests the synergy and Kirin's big health science ambitions.

A new partnership between Interface Systems and Brivo signals a critical shift, moving physical security to the cloud to manage the distributed enterprise.

A new partnership between Evogene and ELEO leverages AI and natural product science to create an oral PCSK9 inhibitor, aiming to disrupt a $23B market.

Marquis MD's new concierge clinic promises a cure for healthcare's frustrations. But as it caters to the elite, does it widen the care gap for everyone else?

Beyond the bus stop, Zūm's tech platform is tackling absenteeism and anxiety, turning a daily commute into a data-driven path to educational equity.

We’ve all seen it: the group trip that dies in the chat. KAYAK is betting a combination of public shaming and smart AI can finally turn those plans into reality.

San Diego's VivoSim Labs enters China, leveraging AI-powered human tissue models that challenge traditional animal testing and aim for safer, faster drug development.

As private equity reshapes healthcare with a focus on short-term returns, one family-owned firm bets its future on a different model: decades-long trust.

Opustone's acquisition by Construction Resources signals a major shift in the luxury materials game, as curated stone becomes a key asset in a booming market.